Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Domperidone for Gastric Residual Volume in Elective Surgery
NCT05570292Phase 3Completed
- Sponsor
- Ain Shams University
- Start
- Oct 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of domperidone (2 arms), sponsored by Ain Shams University. Primary endpoint: Gastric Residual Volume. Started Oct 2022; status: completed.
02
Drugs
domperidone
Beyond the preview
Go deeper on NCT05570292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05570292.